Mereo BioPharma MREO
NASDAQ MREO
$0.31 +0.01 (+2.92%)
At close: Nov 11, 2026 · 4:00 PM EST

Mereo BioPharma (MREO) Beginning Cash Balance (2022 - 2026)

Updated

Analysis

Mereo BioPharma (MREO) Beginning Cash Balance (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Mereo BioPharma 47.91 Mn -79.40 Mn 800,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 551.02 Mn
Dec 31, 2025 549.62 Mn
Mar 31, 2025 544.27 Mn
Dec 31, 2024 539.64 Mn
Mar 31, 2024 486.93 Mn
Dec 31, 2023 486.11 Mn
Dec 31, 2022 476.52 Mn
API Access

Mereo BioPharma Beginning Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=beginning-cash-balance&ticker=MREO&period=max&api_key=YOUR_API_KEY